Author:The British Pharmacopoeia Commission Secretariat of the
Medicines and Healthcare products Regulatory Agency (MHRA)
Publisher: TSO (The Stationery Office)
Legally enforced standards, available from 1
August 2018. All European Pharmacopoeial texts included.
Superseded by the
British Pharmacopoeia 2020.
Updated annually, the British Pharmacopoeia (BP) is the only comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products.
It includes approximately 4,000 monographs which are legally enforced by the Human Medicines Regulations 2012. Where a BP monograph exists, medicinal products or active pharmaceutical ingredients sold or supplied in the UK must comply with the relevant monograph.
All monographs and requirements of the European Pharmacopoeia (Ph. Eur.) are reproduced in the BP, making the BP a convenient and fully comprehensive set of standards that can be used across Europe and beyond.
New for the BP 2019
The BP 2019 supersedes the BP 2018 and becomes legally effective on 1 January 2019. This edition incorporates new monographs from both the BP and Ph. Eur. along with a significant number of revised monographs.
- 27 new BP monographs, 39 new Ph. Eur. monographs
- 117 amended BP monographs
- Four new monographs for unlicensed formulations and two new monographs for herbal preparations
- Two new monographs for biological medicines
- One new and six amended BP Veterinary monographs
- All monographs from the Ph. Eur. 9th Edition and Supplements 9.1 to 9.5 included
- Three in-year online and offline download product updates to integrate the Ph. Eur. Supplements 9.6, 9.7 and 9.8
Key customer groups
The BP is a must have for suppliers and sellers of active pharmaceutical ingredients and medicinal products in the UK. For corporate pharmaceutical organisations to develop high-quality medicinal products in compliance with regulations, the BP 2019 features a variety of important monograph updates providing users with the information they need to maintain compliance. This helps mitigate against any issues supplying or selling products later on.
Key corporate customers include: Pharmaceutical researchers and manufacturers, chemists, biotechnologists, quality assurance and quality controls inspectors, laboratory technicians and regulatory bodies.
Flexible options for single and multiple users are available for the BP Online.
Specialist researchers and lecturers in the field of pharmacy, biological science, biochemistry and pharmaceutical science can use the BP for research into medicinal products using the most up-to-date monographs.
Flexible options and discounts are available for our academic customers.Show less
The complete package is a great value-for-money option including:
- A six-volume printed edition, including the BP (Veterinary) 2019
- A single-user online licence*
- A single-user download for offline use*
Other formats and bundles are available to ensure you get the best value access to the information you need.
Add the BP Archive option to your standard package and receive online access to all the BP editions from 2014 to date. The Archive is a useful tool that enables you to switch between different versions of a monograph by publication to help users track what's changed.
Online users can also choose to add the British Approved Names (BAN) 2017 & Supplement No.2 to their package, gaining easy access to this useful reference source of medicinal substance names.
*These single-user licences are granted solely to the designated holder of the product within an organisation. Multi-user licences are available.